Blog Viewer

Open Comment Period for SITC’s Melanoma Guideline Closes March 16

By SITC Guideline News posted 25 days ago


The Society for Immunotherapy of Cancer (SITC) Melanoma Immunotherapy Guideline Expert Panel is pleased to invite public comment on the draft clinical practice guideline (CPG) “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma,” an update to the society’s 2018 CPG for this disease setting.

During SITC’s open comment period, key stakeholders and other experts in the field may critically review a confidential copy of the CPG draft and provide input prior to its publication. More information on how to gain access to the draft manuscript can be found on the open comment page of the SITC website. All comments are due to SITC by March 16, 2023.

If you have questions about this open comment period or would like more details about the society’s other immunotherapy CPGs, please email